76 related articles for article (PubMed ID: 23071629)
21. Cell-based resorption assays for bone graft substitutes.
Zhang Z; Egaña JT; Reckhenrich AK; Schenck TL; Lohmeyer JA; Schantz JT; Machens HG; Schilling AF
Acta Biomater; 2012 Jan; 8(1):13-9. PubMed ID: 21971416
[TBL] [Abstract][Full Text] [Related]
22. The role of osteoclasts in bone tissue engineering.
Detsch R; Boccaccini AR
J Tissue Eng Regen Med; 2015 Oct; 9(10):1133-49. PubMed ID: 24478169
[TBL] [Abstract][Full Text] [Related]
23. Divergent resorbability and effects on osteoclast formation of commonly used bone substitutes in a human in vitro-assay.
Keller J; Brink S; Busse B; Schilling AF; Schinke T; Amling M; Lange T
PLoS One; 2012; 7(10):e46757. PubMed ID: 23071629
[TBL] [Abstract][Full Text] [Related]
24. In vitro osteoclast resorption of bone substitute biomaterials used for implant site augmentation: a pilot study.
Taylor JC; Cuff SE; Leger JP; Morra A; Anderson GI
Int J Oral Maxillofac Implants; 2002; 17(3):321-30. PubMed ID: 12074446
[TBL] [Abstract][Full Text] [Related]
25. Resorbability of bone substitute biomaterials by human osteoclasts.
Schilling AF; Linhart W; Filke S; Gebauer M; Schinke T; Rueger JM; Amling M
Biomaterials; 2004 Aug; 25(18):3963-72. PubMed ID: 15046886
[TBL] [Abstract][Full Text] [Related]
26. In vitro effects of particulate bone substitute materials on the resorption activity of human osteoclasts.
Russmueller G; Winkler L; Lieber R; Seemann R; Pirklbauer K; Perisanidis C; Kapeller B; Spassova E; Halwax E; Poeschl WP; Macfelda K; Moser D
Eur Cell Mater; 2017 Oct; 34():291-306. PubMed ID: 29064533
[TBL] [Abstract][Full Text] [Related]
27. Influence of Cu
Bernhardt A; Bacova J; Gbureck U; Gelinsky M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671069
[TBL] [Abstract][Full Text] [Related]
28. An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes.
Abdallah D; Jourdain ML; Braux J; Guillaume C; Gangloff SC; Jacquot J; Velard F
Front Immunol; 2018; 9():632. PubMed ID: 29670619
[TBL] [Abstract][Full Text] [Related]
29. Metabolic bone diseases.
Horvai AE; Boyce BF
Semin Diagn Pathol; 2011 Feb; 28(1):13-25. PubMed ID: 21675374
[No Abstract] [Full Text] [Related]
30. Size dependent induction of proinflammatory cytokines and cytotoxicity of particulate beta-tricalciumphosphate in vitro.
Lange T; Schilling AF; Peters F; Mujas J; Wicklein D; Amling M
Biomaterials; 2011 Jun; 32(17):4067-75. PubMed ID: 21421269
[TBL] [Abstract][Full Text] [Related]
31. Osteoclastic bioresorption of biomaterials: two- and three-dimensional imaging and quantification.
Winkler T; Hoenig E; Huber G; Janssen R; Fritsch D; Gildenhaar R; Berger G; Morlock MM; Schilling AF
Int J Artif Organs; 2010 Apr; 33(4):198-203. PubMed ID: 20458689
[TBL] [Abstract][Full Text] [Related]
32. TNF and bone.
David JP; Schett G
Curr Dir Autoimmun; 2010; 11():135-44. PubMed ID: 20173392
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional characterization of osteoclast bone-resorbing activity in the resorption lacunae.
Soysa NS; Alles N; Aoki K; Ohya K
J Med Dent Sci; 2009 Sep; 56(3):107-12. PubMed ID: 20099473
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of combination use of antibiotic-loaded PerOssal with spinal surgery in patients with spondylodiscitis.
von Stechow D; Rauschmann MA
Eur Surg Res; 2009; 43(3):298-305. PubMed ID: 19684405
[TBL] [Abstract][Full Text] [Related]
35. Proinflammatory and osteoclastogenic effects of beta-tricalciumphosphate and hydroxyapatite particles on human mononuclear cells in vitro.
Lange T; Schilling AF; Peters F; Haag F; Morlock MM; Rueger JM; Amling M
Biomaterials; 2009 Oct; 30(29):5312-8. PubMed ID: 19577291
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating.
Schnettler R; Knöss PD; Heiss C; Stahl JP; Meyer C; Kilian O; Wenisch S; Alt V
J Biomed Mater Res B Appl Biomater; 2009 Jul; 90(1):75-81. PubMed ID: 19016453
[TBL] [Abstract][Full Text] [Related]
37. The efficacy of Biobon and Ostim within metaphyseal defects using the Göttinger Minipig.
Spies CK; Schnürer S; Gotterbarm T; Breusch S
Arch Orthop Trauma Surg; 2009 Jul; 129(7):979-88. PubMed ID: 18677495
[TBL] [Abstract][Full Text] [Related]
38. Effect of beta-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans.
Knabe C; Koch C; Rack A; Stiller M
Biomaterials; 2008 May; 29(14):2249-58. PubMed ID: 18289665
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
